Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 Biomarker BEFREE Eighty ASA physical status 1-2 patients scheduled for shoulder arthroscopy under general anaesthesia with ultrasound-guided interscalene brachial plexus block were randomly allocated to receive saline (control), dexamethasone 1 mg, 2 mg, 3 mg and 4 mg, together with 20 ml ropivacaine 0.5%. 30973188

2019

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 Biomarker BEFREE We studied 74 paediatric patients aged 0-24 months of ASA physical status 1-3 who were scheduled for elective surgery under general anaesthesia. 30987765

2019

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 Biomarker BEFREE Longer duration of anaesthesia, inhalational anaesthesia and ASA ≥3 were significantly associated to this. 31241184

2019

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 Biomarker BEFREE A logistic regression analysis with risk factors (age, ASA physical status, emergency) was used to evaluate the impact of implementation of the specialised paediatric anaesthesia team. 30048261

2019

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 GeneticVariation BEFREE Twenty-two adult ASA I to III patients scheduled to undergo elective surgical procedures under general anaesthesia requiring administration of a neuromuscular blocking agent were included. 30446866

2019

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 GeneticVariation BEFREE Two-hundred and three ASA I-II patients, <18 years of age (mean: 5.3 ± 2.4 years) were included in the prospective observational study whose comprehensive dental treatment was performed under general anaesthesia. 28108831

2018

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 GeneticVariation BEFREE Children (1-16 yr old, ASA I or II) undergoing elective procedures with general anaesthesia requiring tracheal intubation were randomised for clear fluid intake until premedication with midazolam (liberal) or 2 h fluid fasting (standard).Actual fasting times were recorded. 30115263

2018

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 Biomarker BEFREE We evaluated ASA physical status III and IV patients who had non-cardiac surgery with general anaesthesia at the Cleveland Clinic. 29452806

2018

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 Biomarker BEFREE In a prospective, open label, observational study, 292 ASA physical status classification 1 and 2 patients at low risk of pulmonary aspiration undergoing upper gastrointestinal endoscopy received i.v. propofol anaesthesia and standardized insertion of the LMA<sup>®</sup>Gastro<sup>TM</sup> Airway. 29406183

2018

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 Biomarker BEFREE Age, sex, height, weight, ASA physical status, days in hospital before anaesthesia, number of anaesthetics per child, indications for anaesthesia, methods of anaesthesia, airway management and complications were all recorded. 29672828

2018

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 GeneticVariation BEFREE Thirty-one adult ASA I-III patients undergoing long-duration (>3 hours) sevoflurane anaesthesia for major head and neck surgery were included and randomized to IHV-treatment (n = 16) or control (n = 15). 29671866

2018

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 Biomarker BEFREE Female cats (American Society of Anesthesiologists [ASA] grade I) undergoing elective surgery by laparotomy under general anaesthesia (acepromazine 0.05 mg/kg SC; morphine 0.2 mg/kg IV; propofol IV titrated, isoflurane 2% in 100% oxygen) were randomised in two groups. 28121211

2017

Entrez Id: 410
Gene Symbol: ARSA
ARSA
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.100 Biomarker BEFREE Children with an ASA physical state classification of I or II, aged from 4 to 16 years and scheduled for elective circumcision or inguinal hernia repair under combined general and caudal anaesthesia were included. 28685824

2017

Entrez Id: 9531
Gene Symbol: BAG3
BAG3
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.050 Biomarker BEFREE In 79 courses of anaesthesia, BIS monitor-derived EMG parameters (EMGLOW), and other processed EEG parameters [SEF95 (spectral edge frequency 95%), SynchFastSlow (bispectral parameter), BetaRatio (frequency parameter), total power subtypes in five frequency range], were obtained simultaneously with BIS, every 3 s. These EEG parameters were used for receiver operating characteristic (ROC) analysis of detecting three BIS levels (BIS > 80, BIS > 70, and BIS > 60) to assess their diagnosabilities. 30607805

2019

Entrez Id: 9531
Gene Symbol: BAG3
BAG3
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.050 Biomarker BEFREE We randomly assigned patients who had increased risk of complications after major surgery to receive light general anaesthesia (bispectral index [BIS] target 50) or deep general anaesthesia (BIS target 35). 31645286

2019

Entrez Id: 9531
Gene Symbol: BAG3
BAG3
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.050 Biomarker BEFREE Whilst BIS target values differed between studies, all were within a range of values between 40 to 60.BIS versus clinical signsWe found low-certainty evidence that BIS-guided anaesthesia may reduce the risk of intraoperative awareness in a surgical population that were unselected or at high risk of awareness (Peto odds ratio (OR) 0.36, 95% CI 0.21 to 0.60; I<sup>2</sup> = 61%; 27 studies; 9765 participants). 31557307

2019

Entrez Id: 9531
Gene Symbol: BAG3
BAG3
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.050 Biomarker BEFREE Following administration of a spinal anaesthetic, patients received either sevoflurane (n=121) or propofol (n=171) at the discretion of the anaesthetist for maintenance of general anaesthesia to maintain the processed electroencephalogram (bispectral index, BIS) under 60. 30447669

2018

Entrez Id: 9531
Gene Symbol: BAG3
BAG3
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.050 Biomarker BEFREE Percentage of total anaesthesia time ("valid CLADS time") for which BIS remained within ±10 of target (BIS=50). 28865915

2017

Entrez Id: 100379198
Gene Symbol: ECT
ECT
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.040 Biomarker BEFREE In this study, our aim was to examine the effect of the time interval between anaesthetic induction and the ECT stimulus for ictal seizure quality in ECT sessions utilising thiopentone anaesthesia. 30981950

2019

Entrez Id: 100379198
Gene Symbol: ECT
ECT
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.040 Biomarker BEFREE Electrocardiography (ECG) recordings were obtained before anaesthesia and within 3-5 min after electrical stimulus of ECT for measurements. 29477501

2019

Entrez Id: 100379198
Gene Symbol: ECT
ECT
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.040 Biomarker BEFREE Ketamine as anaesthesia for ECT: is there room to improve a gold standard treatment? 29486819

2018

Entrez Id: 100379198
Gene Symbol: ECT
ECT
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.040 Biomarker BEFREE Meta-analyses, randomised controlled trials, open-label and retrospective studies published in English of depressed samples receiving ECT with ketamine anaesthesia were included (n = 24). 27892759

2017

Entrez Id: 10558
Gene Symbol: SPTLC1
SPTLC1
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.030 GeneticVariation BEFREE Hereditary sensory neuropathy type I (HSN I) is an axonal form of autosomal-dominant hereditary motor and sensory neuropathy distinguished by prominent sensory loss that leads to painless injuries. 21194679

2011

Entrez Id: 6261
Gene Symbol: RYR1
RYR1
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.030 GeneticVariation BEFREE Differences in phenotype severity between RYR1 variants may explain the variability in clinical penetrance of MH during anaesthesia and why some variants have been associated with exercise-induced rhabdomyolysis and heat stroke. 19648156

2009

Entrez Id: 10558
Gene Symbol: SPTLC1
SPTLC1
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.030 Biomarker BEFREE Hereditary sensory neuropathy type I (HSN I) is a slowly progressive neurological disorder characterised by prominent predominantly distal sensory loss, autonomic disturbances, autosomal dominant inheritance, and juvenile or adulthood disease onset. 18348718

2008